Table 1.
Baseline patient characteristics a.
Table 2.
Effectiveness outcomes.
Fig 1.
Overall survival curve for all patients (n = 20).
Median OS (months): 9.2 (95%CI: 6.3 to not reached).
Fig 2.
Progression-free survival curve for all patients (n = 20).
Median PFS (months): 7.3 (95%CI: 5.3 to not reached).
Table 3.
Safety: Toxicity events, grade and treatment.
Table 4.
Healthcare resources utilization.
Table 5.
Costing by stage.
Table 6.
Costing by activity.